Aroundtown H1 FY26 profit drops 62% to €218.1 million; revenue rises 0.44% to €761.7 million

Reuters2026/08/26 10:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aroundtown posted H1 2026 profit of EUR 218.1 million, down 62% year over year; basic EPS fell to EUR 0.08.
Revenue edged up 0.44% to EUR 761.7 million; net rental income was flat at EUR 590.6 million.
Operating profit slumped to EUR 472.1 million from EUR 864.1 million, as property revaluations and capital gains dropped to EUR 1.7 million.
Adjusted EBITDA (non-IFRS) was steady at EUR 500 million, while FFO I (non-IFRS) fell 4% to EUR 143.8 million.
Maintained FY 2026 FFO I guidance of EUR 275 million–EUR 305 million; dividend per share outlook set at EUR 0.12–EUR 0.135.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aroundtown SA published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23